Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025:2834:303-332.
doi: 10.1007/978-1-0716-4003-6_15.

Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity

Affiliations
Review

Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity

Antonio Lopalco et al. Methods Mol Biol. 2025.

Abstract

In the last three decades, the development of nanoparticles or nano-formulations as drug delivery systems has emerged as a promising tool to overcome the limitations of conventional delivery, potentially to improve the stability and solubility of active molecules, promote their transport across the biological membranes, and prolong circulation times to increase efficacy of a therapy. Despite several nano-formulations having applications in drug delivery, some issues concerning their safety and toxicity are still debated. This chapter describes the recent available information regarding safety, toxicity, and efficacy of nano-formulations for drug delivery. Several key factors can influence the behavior of nanoparticles in a biological environment, and their evaluation is crucial to design non-toxic and effective nano-formulations. Among them, we have focused our attention on materials and methods for their preparation (including the innovative microfluidic technique), mechanisms of interactions with biological systems, purification of nanoparticles, manufacture impurities, and nano-stability. This chapter places emphasis on the utilization of in silico, in vitro, and in vivo models for the assessment and prediction of toxicity associated with these nano-formulations. Furthermore, the chapter includes specific examples of in vitro and in vivo studies conducted on nanoparticles, illustrating their application in this field.

Keywords: Biomimetics; Drug delivery; Efficacy; Hybrids; Microfluidics; Nano-formulation; Nanoparticle; Nanotechnology; Nanotoxicity; Polymer; Safety; Toxicity; mRNA vaccines.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lopalco A, Denora N (2018) Nanoformulations for drug delivery: safety, toxicity, and efficacy. Methods Mol Biol 1800:347–365. https://doi.org/10.1007/978-1-4939-7899-1_17 - DOI - PubMed
    1. Bawa R (2015) Nanopharmaceuticals for drug delivery – a review. Eur J Nanomedicine:122–127. https://doi.org/10.1002/9781394167708.ch2
    1. Weissig V, Pettinger TK, Murdock N (2014) Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine:4357–4373. https://doi.org/10.2147/IJN.S46900
    1. De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3:133–149. https://doi.org/10.2147/ijn.s596 - DOI - PubMed - PMC
    1. Ailuno G, Iacobazzi RM, Lopalco A et al (2021) The pharmaceutical technology approach on imaging innovations from Italian research. Pharmaceutics 13:1214. https://doi.org/10.3390/pharmaceutics13081214 - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources